http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9100259-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03721e344a72026d125291e6c56c1be6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 1990-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54f3d3df40d16b76e9f20c5e8905ccd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b2873d6f2483017096a95e1ea99088 |
| publicationDate | 1991-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9100259-A1 |
| titleOfInvention | D-propranolol as a selective adenosine antagonist |
| abstract | Chemicals useful for inhibiting the action of adenosine in mammals, comprising: propanolol-L or propanolol-D, or alprenolol, and their derivatives for parenteral or topical administration are described for carrying out the desired concentrations ranging from 10 nanograms to 10 milligrams per kilogram. Propanolol-D is particularly interesting because it is relatively inactive as a beta adrenergic blocking agent. Specific uses of propanolol-D include the treatment of asthma, chronic obstructive pulmonary disease, AV nodal conduction disorders, apnea of premature infants, pulmonary hypertension, headache, migraine, attention deficit. Propanolol can also be used as a substitute for xanthines in beverages to produce a feeling of well-being, arousal, awareness and increased performance. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03072105-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003208170-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071630-B2 |
| priorityDate | 1989-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.